Winton Group LTD Amicus Therapeutics, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$8.38 - $13.44 $127,845 - $205,040	-15,256 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$11.6 - $16.54 $4,860 - $6,930	419 Added 2.82%	15,256 $0
Q2 2018 Aug 20, 2018	SELL	$13.13 - $17.09 $139,335 - $181,359	-10,612 Reduced 41.7%	14,837 $0
Q1 2018 May 21, 2018	BUY	$13.76 - $17.12 $350,178 - $435,686	25,449 New	25,449 $0

311

283M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.44B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.